Yüklüyor......
Bioequivalence study of two subcutaneous formulations of dalteparin: randomized, single-dose, two-sequence, two-period, cross-over study in healthy volunteers
OBJECTIVE: This study assessed relative bioavailability of a new subcutaneous formulation, test (T) (dalteparin sodium 95000 IU/3.8 mL) with the branded product (R) in healthy subjects to meet the regulatory requirements of bioequivalence in the US. METHODS: This was an open label, randomized, singl...
Kaydedildi:
| Yayımlandı: | J Drug Assess |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Maney Publishing
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4937650/ https://ncbi.nlm.nih.gov/pubmed/27536434 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/21556660.2013.781504 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|